Healx

📍 Cambridge, United Kingdom🗓 Founded 2014👥 64 employees💰 Last funded Dec 2024
Healx is a mission-driven technology company pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are more than 10,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact.
13
Total investors
1
Early stage
8
Mid stage
4
Late stage
2014
Founded

Investors

13 investors
All
Early stage
Mid stage
Late stage
Investor geography4 countries
United Kingdom
5
United States
5
Germany
2
Switzerland
1
Investor activity2015–2024 · investors recorded per year
2015120183201952022120243
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Healx?
Healx has 13 investors on record on gritt.io, including 1 early-stage backers, 8 mid-stage and 4 late-stage investors.
When did Healx last raise funding?
The most recent investment in Healx recorded on gritt.io was in December 2024.
When was Healx founded?
Healx was founded in 2014.
What industry is Healx in?
Healx operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Healx based?
Healx is headquartered in Cambridge, United Kingdom.